Aisling Capital Management LP - NABRIVA THERAPEUTICS PLC ownership

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 29 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Aisling Capital Management LP ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$16,000
-80.0%
90,000
-52.9%
0.01%
-74.4%
Q1 2022$80,000
-29.8%
191,0280.0%0.04%
+7.5%
Q4 2021$114,000
-49.8%
191,0280.0%0.04%
-11.1%
Q3 2021$227,000
-12.0%
191,0280.0%0.04%
+9.8%
Q2 2021$258,000
-18.6%
191,0280.0%0.04%
-28.1%
Q1 2021$317,000191,0280.06%
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 45,849$19,0001.30%
Aisling Capital Management LP 191,028$80,0000.04%
Frazier Life Sciences Management, L.P. 425,650$179,0000.02%
Values First Advisors, Inc. 44,951$19,0000.01%
Running Point Capital Advisors, LLC 10,000$4,0000.00%
Virtu Financial LLC 79,556$33,0000.00%
CCG WEALTH MANAGEMENT, LLC 10,000$4,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
PARAMETRIC PORTFOLIO ASSOCIATES LLC 26,300$11,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 42,738$17,0000.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders